Sanofi Consumer Healthcare India Ltd Share Price Today, Live NSE/BSE Updates

Sanofi Consumer Healthcare India Ltd Share Price

NSEBSE

There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.

Max

Open4,025

High4,355

Low4,000.5

Prev. Close4,298.2

Avg. Traded Price4,220.82

Volume38,980

MARKET DEPTH

Total bid0.00

Total ask7.00

Orders	Qty	Bid
0	0	0
0	0	0
0	0	0
0	0	0
0	0	0

Ask	Qty	Orders
4298.2	3	7
0	0	0
0	0	0
0	0	0
0	0	0

HIGH/LOW

52w

LOW/HIGH

₹4370.002 days ago

₹4610.002 days ago

LOWER/UPPER CIRCUITS

₹3628.60

₹5442.80

Sanofi Consumer Healthcare India Ltd Stock performance

KEY OBSERVATIONS

positive

negative

neutral

Annual Revenue,rose 21.6%, in the last year to ₹896.8 Cr. Its sector's average revenue growth for the last fiscal year was 10.77%.

Annual Net Profit,rose 32.65% in the last year to ₹240.1 Cr. Its sector's average net profit growth for the last fiscal year was 36.82%.

Return on Equity(ROE),for the last financial year was 62.52%, more than 20% in the last financial year, indicating an efficient use of shareholder's capital to generate profit.

Similar stocks

SUNPHARMA₹1693.60-34.90 (2.02%)

DIVISLAB₹5856.50-50.00 (0.85%)

TORNTPHARM₹3987.20-124.10 (3.02%)

LUPIN₹2274.50-0.40 (0.02%)

DRREDDY₹1217.30+7.70 (0.64%)

Sanofi Consumer Healthcare India Limited (SCHIL)

Sanofi Consumer Healthcare India Limited (SCHIL) was incorporated on May 10, 2023, following the demerger of Sanofi India Limited’s consumer healthcare division. The Company became an independent, focused entity to provide science-backed consumer healthcare solutions. With trusted brands such as Allegra®, Combiflam®, Avil®, and DePURA®, SCHIL operates across allergy relief, pain management, physical wellness, and overall healthcare needs. SCHIL was successfully listed on BSE (Scrip Code: 544250) and NSE (Symbol: SANOFICONR) on September 13, 2024.

Its extensive distribution spans pharmacies, hospitals, retail chains, government institutions, and e-commerce platforms, ensuring wide accessibility of its products. Sanofi retained a 60.4% stake in SCHIL post demerger, with 39.6% held by the public.

Business Segments:

SCHIL’s portfolio is built around three major healthcare segments:

Allergy Relief: Allegra and Avil lead in this category, with Allegra being India’s #1 oral allergy brand for over 15 years.
Pain Management: Combiflam, one of India’s most trusted pain-relief brands, sold over 62 million tablets in 2023.
Wellness & Nutrition: DePURA Vitamin D3 solutions cater to physical wellness needs.

Key Management:

Mr. Himanshu Bakshi – Managing Director
Ms. Maithilee Mistry – Whole-time Director & Chief Financial Officer
Mr. Nikunjkumar Savaliya – Company Secretary & Compliance Officer
Independent Directors: Mr. Amit Jain, Mr. Shobinder Duggal, Ms. Suparna Pandhi
Non-Executive Directors: Ms. Carol-Ann Stewart, Mr. Stanislas Camart

Latest Updates:

Successfully listed on BSE and NSE in September 2024.
Relocated its registered office to Godrej Two, Vikhroli, Mumbai, effective January 1, 2025.
Announced its 2nd Annual General Meeting (AGM) to be held on May 5, 2025, via VC/OAVM.
Dividend payment scheduled on or after May 20, 2025.
Strengthened digital presence by focusing on e-commerce, quick commerce, and modern trade as primary growth channels.